FHIR IG analyticsBy Version
By Authority
By Realm
Start Prev Rows 6600 - 6800 Next
| Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Realm | Auth | Resource | Usage # |
|---|---|---|---|---|---|---|---|---|---|---|---|
| johnmoehrke.testbinary.example | R4 | StructureDefinition-MediaFoo.json | Just a simple profile of Media | draft | 2026-06 | uv | Media | ||||
| medcom.fhir.dk.core | R4 | StructureDefinition-medcom-core-media.json | MedComMedia | active | 2026-01 | dk | Media | 1 | |||
| StandardPatientHealthRecordIG | R4 | StructureDefinition-PhrMedia.json | PhrMedia | draft | 2023-09 | Media | |||||
| hl7.fhir.uv.phr.r4 | R4 | StructureDefinition-PhrMedia.json | PhrMedia | trial-use | 1 | pe | 2025-04 | uv | hl7 | Media | |
| nictiz.fhir.nl.r4.nl-core | R4 | nl-core-TextResult.VisualResult.json | nl core TextResult.VisualResult | draft | nl | Media | 1 | ||||
| hl7.fhir.uv.xver-r2.r4b | R4B | StructureDefinition-profile-Media.json | Cross-version Profile for DSTU2.Media for use in FHIR R4B | trial-use | 0 | fhir | 2026-03 | uv | hl7 | Media | |
| hl7.fhir.uv.xver-r4.r4b | R4B | StructureDefinition-profile-Media.json | Cross-version Profile for R4.Media for use in FHIR R4B | trial-use | 0 | fhir | 2026-03 | uv | hl7 | Media | 1 |
| hl7.fhir.uv.xver-r4b.r4 | R4 | StructureDefinition-profile-Media.json | Cross-version Profile for R4B.Media for use in FHIR R4 | trial-use | 0 | fhir | 2026-03 | uv | hl7 | Media | 1 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition-profile-DocumentReference-for-Media.json | Cross-version Profile for R5.DocumentReference for use in FHIR R4 | trial-use | 0 | fhir | 2026-03 | uv | hl7 | Media | 18 |
| hl7.fhir.uv.xver-r3.r4b | R4B | StructureDefinition-profile-Media.json | Cross-version Profile for STU3.Media for use in FHIR R4B | trial-use | 0 | fhir | 2026-03 | uv | hl7 | Media | |
| hl7.fhir.cz.img | R4 | StructureDefinition-cz-media-obl-img.json | Media: Obligations | draft | 2026-08 | cz | hl7 | Media | |||
| hl7.fhir.cz.lab | R4 | StructureDefinition-cz-attachment-obl-lab.json | Attachment: Obligations | draft | 2026-08 | cz | hl7 | Media | |||
| ndhm.in | R4 | StructureDefinition-Media.json | Media | draft | 2020-08 | in | national | Media | 4 | ||
| hl7.fhir.vn.core | R4 | StructureDefinition-vn-core-media-observation.json | Media Observation profile - VN Core R4 | draft | 2026-05 | vn | hl7 | Media | 1 | ||
| nictiz.fhir.nl.r4.zib2020 | R4 | zib-TextResult.VisualResult.json | zib TextResult.VisualResult | draft | nl | hl7 | Media | 1 | |||
| kr.mohw.myhealthway | R4 | StructureDefinition-myhealthway-media.json | MyHealthWay Media Profile | active | 2024-04 | Media | 6 | ||||
| tw.gov.mohw.emr | R4 | StructureDefinition-MediaDMSFamily.json | 出院病摘-家族圖譜 | active | 2022-12 | tw | national | Media | 4 | ||
| tw.gov.mohw.emr | R4 | StructureDefinition-MediaDMSImagingStudy.json | 出院病摘-醫學影像檢查(Media) | active | 2022-12 | tw | national | Media | 4 | ||
| tw.gov.mohw.nhi.empd | R4 | StructureDefinition-Media-DS.json | 調劑單張-領藥者數位簽章 | active | 2024-01 | tw | national | Media | 4 | ||
| tw.gov.mohw.emr | R4 | StructureDefinition-Media-DS.json | 調劑單張-領藥者數位簽章 | active | 2024-01 | tw | national | Media | 4 | ||
| tw.gov.mohw.emr | R4 | StructureDefinition-PMRFamilyTreeMedia.json | 門診病歷-家族圖譜 | active | 2025-01 | tw | national | Media | 4 | ||
| tw.gov.mohw.emr | R4 | StructureDefinition-PMROutpatientImageMedia.json | 門診病歷-門診圖像 | active | 2025-01 | tw | national | Media | 4 | ||
| tw.gov.mohw.twcore | R4 | StructureDefinition-Media-twcore.json | TW Core Media | active | 2026-05 | tw | national | Media | 46 | ||
| tw.gov.mohw.nhi.pas | R4 | StructureDefinition-Media-twpas.json | 非DICOM影像-Media TWPAS | active | 2026-08 | tw | national | Media | 5 | ||
| iknl.fhir.nl.r4.ncr-ehr | R4 | StructureDefinition-ncr-ehr-medication.json | NcrEhrMedication | draft | 2026-01 | nl | Medication | 2 | |||
| kbv.ita.erp | R4 | KBV_PR_ERP_Medication_Compounding.json | KBV_PR_ERP_Medication_Compounding | active | 2026-07 | Medication | 7 | ||||
| kbv.ita.erp | R4 | KBV_PR_ERP_Medication_FreeText.json | KBV_PR_ERP_Medication_FreeText | active | 2026-07 | Medication | 7 | ||||
| kbv.ita.erp | R4 | KBV_PR_ERP_Medication_Ingredient.json | KBV_PR_ERP_Medication_Ingredient | active | 2026-07 | Medication | 7 | ||||
| kbv.ita.erp | R4 | KBV_PR_ERP_Medication_PZN.json | KBV_PR_ERP_Medication_PZN | active | 2026-07 | Medication | 7 | ||||
| fhir.r4.wales.test | R4 | Profile-DataStandardsWales-Medication.json | Data Standards Wales Medication | active | 2023-08 | us | hl7 | Medication | 6 | ||
| fdpg.query_profiles | R4 | FDPG_Medikation.json | Medikation | active | Medication | ||||||
| eng.fhir.profile.dev | R4 | Medication_Eng.StructureDefinition.json | Medication_Eng | draft | 2022-12 | hl7 | Medication | 2 | |||
| eng.fhir.profile.dev | R4 | Medication_composti_Eng.StructureDefinition.json | Medication_composti_Eng | draft | 2022-12 | hl7 | Medication | 3 | |||
| eng.fhir.profile.dev | R4 | Medication_semplice_Eng.StructureDefinition.json | Medication_semplice_Eng | draft | 2023-03 | hl7 | Medication | 4 | |||
| rl.fhir.r4.draft | R4 | Profile_RLMedicationLDO.json | RLMedicationLDO | draft | Medication | 2 | |||||
| telus.dw.emr.extract | R4 | DwMedication.StructureDefinition.json | DwMedication | draft | 2024-05 | Medication | |||||
| synapxe.nde | R5 | Medication.StructureDefinition.json | Medication | draft | Medication | 12 | |||||
| uk.nhsdigital.r4.test | R4 | NHSDigital-MedicationDispense-Medication.StructureDefinition.json | NHSDigitalMedicationDispenseMedication | draft | Medication | 1 | |||||
| uk.nhsdigital.r4.test | R4 | NHSDigital-MedicationRequest-Medication.StructureDefinition.json | NHSDigitalMedicationRequestMedication | draft | Medication | 4 | |||||
| implementation.guide.nhdr | R4 | PH_Medication.StructureDefinition.json | PH_Medication | draft | Medication | ||||||
| nexuzhealth.fhir.r4 | R4 | NxhChemoCompoundMedication.StructureDefinition.json | NxhChemoCompoundMedication | active | 2023-12 | Medication | |||||
| se.electronichealth.fhir.nll.r4 | R4 | NLLMedication.StructureDefinition.json | NLLMedication | active | 2025-04 | Medication | |||||
| sfm.130323 | R4 | HSOMedication.StructureDefinition.json | HSOMedication | draft | Medication | ||||||
| kbv.ita.aws | R4 | KBV_PR_AW_Medikament.json | KBV_PR_AW_Medikament | active | Medication | 5 | |||||
| ng.gov.digitalhealth.fhir-ig | R4 | StructureDefinition-ng-medication.json | NG Medication | draft | 2026-06 | Medication | 6 | ||||
| org.dhin-hie.sandbox | R4 | StructureDefinition-ng-medication.json | NG Medication | draft | 2026-06 | Medication | 6 | ||||
| ans.fhir.fr.eprescription | R4 | StructureDefinition-fr-medication-compound.json | FR Medication Compound | draft | 2026-07 | fr | Medication | 2 | |||
| vzvz.covid-vaccinations | R4 | nl-vzvz-rivm-Lotnumber.json | nl vzvz rivm Lotnumber | draft | Medication | ||||||
| hl7.fhir.us.smp | R4 | StructureDefinition-smp-medication.json | Standardized Medication Profile - Medication | trial-use | 1 | phx | 2023-10 | us | hl7 | Medication | 4 |
| hl7.fhir.us.breastcancer | R3 | StructureDefinition-cimi-entity-Medication.json | BC Medication Profile | draft | 2018-08 | us | hl7 | Medication | 2 | ||
| ch.fhir.ig.ch-core | R4 | StructureDefinition-ch-core-medication.json | CH Core Medication | active | 2026-06 | ch | hl7 | Medication | 20 | ||
| test.no.basis | R4 | no-basis-Medication.StructureDefinition.json | no-basis-Medication | active | 2019-07 | Medication | 2 | ||||
| hl7.at.fhir.elga.emed.r4 | R4 | StructureDefinition-at-elga-emed-medication-medikation.json | AT ELGA e-Medikation Medication Medikation | draft | 2026-07 | hl7 | Medication | 3 | |||
| pharmacyeclaim.trial | R4 | profile-medication.StructureDefinition.json | Medication | draft | Medication | 1 | |||||
| hl7.fhir.cz.core | R4 | StructureDefinition-medication-cz-mpd.json | Medication (CZ MPD) | trial-use | 2 | 2026-07 | cz | hl7 | Medication | 1 | |
| hl7.fhir.cz.core | R4 | StructureDefinition-medication-cz-core.json | Medication (CZ core) | trial-use | 2 | 2026-07 | cz | hl7 | Medication | 24 | |
| hl7.at.fhir.elga.aps.r4 | R4 | StructureDefinition-at-aps-medication.json | AT APS Medication | active | 2026-06 | hl7 | Medication | 9 | |||
| tiplu.maia.schnittstellendefinition | R4 | StructureDefinition-MaiaMedikament.json | Maia Medikament | active | 2023-02 | Medication | 2 | ||||
| hl7.fhir.us.cdc-opioid-cpg | R4 | StructureDefinition-CNSDepressantMedication.json | CNS Depressant Medication Profile | trial-use | 3 | cds | 2026-06 | us | hl7 | Medication | 1 |
| hl7.fhir.us.cdc-opioid-cpg | R4 | StructureDefinition-AmphetamineMedication.json | Amphetamine Medication Profile | trial-use | 3 | cds | 2026-06 | us | hl7 | Medication | 1 |
| hl7.fhir.us.cdc-opioid-cpg | R4 | StructureDefinition-BarbiturateMedication.json | Barbiturate Medication Profile | trial-use | 3 | cds | 2026-06 | us | hl7 | Medication | 1 |
| hl7.fhir.us.cdc-opioid-cpg | R4 | StructureDefinition-BenzodiazepineMedication.json | Benzodiazepine Medication Profile | trial-use | 3 | cds | 2026-06 | us | hl7 | Medication | 1 |
| hl7.fhir.us.cdc-opioid-cpg | R4 | StructureDefinition-BuprenorphineMedication.json | Buprenorphine Medication Profile | trial-use | 3 | cds | 2026-06 | us | hl7 | Medication | 1 |
| hl7.fhir.us.cdc-opioid-cpg | R4 | StructureDefinition-FentanylMedication.json | Fentanyl Medication Profile | trial-use | 3 | cds | 2026-06 | us | hl7 | Medication | 1 |
| hl7.fhir.us.cdc-opioid-cpg | R4 | StructureDefinition-MethadoneMedication.json | Methadone Medication Profile | trial-use | 3 | cds | 2026-06 | us | hl7 | Medication | 1 |
| hl7.fhir.us.cdc-opioid-cpg | R4 | StructureDefinition-NaloxoneMedication.json | Naloxone Medication Profile | trial-use | 3 | cds | 2026-06 | us | hl7 | Medication | 1 |
| hl7.fhir.us.cdc-opioid-cpg | R4 | StructureDefinition-OpiateMedication.json | Opiate Medication Profile | trial-use | 3 | cds | 2026-06 | us | hl7 | Medication | 1 |
| hl7.fhir.us.cdc-opioid-cpg | R4 | StructureDefinition-OxycodoneMedication.json | Oxycodone Medication Profile | trial-use | 3 | cds | 2026-06 | us | hl7 | Medication | 1 |
| hl7.fhir.us.cdc-opioid-cpg | R4 | StructureDefinition-ExtendedReleaseOpioidMedication.json | Extended Release Opioid Medication Profile | trial-use | 3 | cds | 2026-06 | us | hl7 | Medication | 1 |
| hl7.fhir.us.cdc-opioid-cpg | R4 | StructureDefinition-OpioidMedication.json | Opioid Medication Profile | trial-use | 3 | cds | 2026-06 | us | hl7 | Medication | 2 |
| uk.nhsdigital.r4.test | R4 | NHSDigital-Medication.StructureDefinition.json | NHS Digital Medication | active | 2022-08 | Medication | 6 | ||||
| de.gematik.epa.medication | R4 | StructureDefinition-epa-medication-pzn-ingredient.json | EPA Medication PZN Ingredient | active | 2026-03 | de | Medication | 4 | |||
| de.gematik.epa.medication | R4 | StructureDefinition-epa-medication-pharmaceutical-product.json | EPA Pharmaceutical Product Medication | active | 2026-03 | de | Medication | 4 | |||
| de.gematik.epa.medication | R4 | StructureDefinition-emp-medication.json | eMP Medication | active | 2026-03 | de | Medication | 5 | |||
| de.gematik.epa.medication | R4 | StructureDefinition-epa-medication.json | EPA Medication | active | 2026-03 | de | Medication | 14 | |||
| ch.fhir.ig.ch-emed-epr.r4 | R4 | StructureDefinition-ch-emed-epr-medication.json | CH EMED EPR Medication | draft | 2026-02 | ch | hl7 | Medication | 9 | ||
| ch.fhir.ig.ch-emed | R4 | StructureDefinition-ch-emed-medication.json | CH EMED Medication | active | 2025-12 | ch | hl7 | Medication | 5 | ||
| ch.fhir.ig.ch-vacd | R4 | StructureDefinition-ch-vacd-medication-for-immunization.json | CH VACD Medication For Immunization | draft | 2026-06 | ch | hl7 | Medication | 4 | ||
| ch.fhir.ig.ch-emed-epr.r4 | R4 | StructureDefinition-ch-emed-epr-medication-medicationdispense.json | CH EMED EPR Medication (DIS) | draft | 2026-02 | ch | hl7 | Medication | 2 | ||
| ch.fhir.ig.ch-emed | R4 | StructureDefinition-ch-emed-medication-medicationdispense.json | CH EMED Medication (MedicationDispense) | active | 2025-12 | ch | hl7 | Medication | 3 | ||
| hl7.fhir.cl.clcore | R4 | StructureDefinition-CoreMedicamentoCl.json | CL Medicamento | active | 2026-08 | cl | hl7 | Medication | 4 | ||
| basisprofil.tiplu.de.r4.dev | R4 | StructureDefinition-TipluMedication.json | Tiplu Medikament | active | 2026-05 | Medication | |||||
| de.medizininformatikinitiative.kerndatensatz.medikation | R4 | StructureDefinition-mii-pr-medikation-medication.json | MII PR Medikation Medication | active | 2025-03 | de | Medication | 6 | |||
| dguv.enla | R4 | DGUV_ENLA_PR_MedikationWirkstoff.json | MedikationWirkstoff | draft | Medication | 3 | |||||
| dguv.enla | R4 | DGUV_ENLA_PR_MedikationRezeptur.json | MedikationRezeptur | draft | Medication | 3 | |||||
| kbv.mio.emp | R4 | StructureDefinition-KBV-PR-MIO-EMP-Medication.json | KBV_PR_MIO_EMP_Medication | draft | Medication | 1 | |||||
| kbv.mio.diga | R4 | KBVPRMIODIGAMedication.json | KBV_PR_MIO_DIGA_Medication | active | Medication | 8 | |||||
| dguv.enla | R4 | DGUV_ENLA_PR_MedikationArzneimittel.json | MedikationArzneimittel | draft | Medication | 3 | |||||
| kbv.mio.ueberleitungsbogen | R4 | KBV_PR_MIO_ULB_Medication.json | KBV_PR_MIO_ULB_Medication | active | Medication | 3 | |||||
| dguv.enla | R4 | DGUV_ENLA_PR_MedikationFreitext.json | MedikationFreitext | draft | Medication | 2 | |||||
| de.gematik.isik-medikation | R4 | StructureDefinition-ISiKMedikament.json | ISiKMedikament | active | 2025-12 | de | Medication | 7 | |||
| de.gematik.isik | R4 | StructureDefinition-ISiKMedikament.json | ISiKMedikament | active | 2026-07 | de | Medication | 2 | |||
| ig-ee-medication-scheme | R5 | StructureDefinition-ee-tis-medication-extemporal.json | EETISMedicationExtemporal | draft | 2024-07 | ee | Medication | 3 | |||
| hl7.fhir.uv.crmi | R4 | StructureDefinition-crmi-shareablemedication.json | CRMI Shareable Medication | trial-use | 2 | cds | 2026-07 | uv | hl7 | Medication | |
| ig-ee-medication-scheme | R5 | StructureDefinition-ee-tis-medication-medical-nutrition.json | EETISMedicationMedicalNutrition | draft | 2026-04 | ee | Medication | ||||
| hl7.fhir.cl.corecl | R4 | StructureDefinition-CoreMedicamentoCl.json | CL Medicamento | active | 2022-09 | cl | hl7 | Medication | |||
| hl7.fhir.cl.clips | R4 | StructureDefinition-Medicamento-cl-ips.json | Medicamento | draft | 1 | 2025-12 | cl | hl7 | Medication | 4 | |
| ans.fhir.fr.document-core | R4 | StructureDefinition-fr-medication-document.json | Medication - FR Medication Document | draft | 2026-08 | fr | Medication | 6 | |||
| ans.document.fr.core | R4 | StructureDefinition-fr-medication-document.json | Medication - FR Medication Document | draft | 2026-04 | fr | Medication | 8 | |||
| ans.document.fr.core | R4 | StructureDefinition-fr-medications-combinaison-document.json | Medication - FR Medications Combinaison Document | draft | 2026-04 | fr | Medication | 6 | |||
| ans.fhir.fr.eprescription | R4 | StructureDefinition-fr-medication.json | FR Medication | draft | 2026-07 | fr | Medication | ||||
| fmcna.caredata.fhir.ig.r4 | R4 | StructureDefinition-fmc-medication-profile.json | Fresenius Medication Profile | active | Medication | ||||||
| kbv.basis.ressources.only | R4 | KBV_PR_Base_Medication.json | KBV_PR_Base_Medication | active | 2024-10 | Medication | 14 | ||||
| hl7.eu.fhir.protect-child | R4 | StructureDefinition-immunosuppressant.json | Immunosuppressant | draft | 2026-06 | eu | hl7 | Medication | 1 | ||
| il.core.fhir.r4.2023 | R4 | StructureDefinition-il-core-medication.json | ILCore Medication Profile | draft | 2021-05 | il | national | Medication | 17 | ||
| phis.ig.createtest | R4 | StructureDefinition-krcore-medication.json | KR Core Medication Profile | active | 2023-06 | hl7 | Medication | 4 | |||
| sfm.130323 | R4 | sfm-Magistrell-Medication.StructureDefinition.json | sfm-Magistrell-Medication | active | 2021-05 | Medication | 3 | ||||
| swiss.mednet.fhir | R4 | StructureDefinition-mni-medication.json | MedNet Interface (MNI) - Medication | active | 2025-12 | ch | Medication | 2 | |||
| br.go.ses.medicamentos | R4 | StructureDefinition-medicamento-especializado.json | Medicamento Especializado | draft | 2026-03 | br | Medication | 1 | |||
| br.go.ses.medicamentos | R4 | StructureDefinition-medicamento-gestao-estoque.json | Medicamento para Gestão de Estoque | draft | 2026-03 | br | Medication | 5 | |||
| hl7.fhir.nl.zorgviewer | R3 | StructureDefinition-Medication.json | Medication | active | 2026-08 | nl | hl7 | Medication | 3 | ||
| myhie.v4-test | R4 | StructureDefinition-Medication-my-core.json | Medication (MY Core) | active | 2023-06 | Medication | |||||
| ihe.pharm.meow | R5 | StructureDefinition-IHEMedication.json | Medicinal product | active | 2026-05 | uv | ihe | Medication | 1 | ||
| ihe.pharm.mpd | R5 | StructureDefinition-IHEMedication.json | IHE Medication | active | 2026-06 | uv | ihe | Medication | 3 | ||
| de.gematik.erezept.eu | R4 | StructureDefinition-GEM-ERPEU-PR-Medication.json | EU-Medication | active | 2026-02 | Medication | 2 | ||||
| il.hdp.fhir.r4 | R4 | StructureDefinition-il-hdp-medication.json | ILHDP Medication Profile | draft | 2026-06 | Medication | 6 | ||||
| hl7.org.nz.fhir.ig.formulary | R4B | StructureDefinition-NzfMedication.json | Medication resource for NZ Formulary | active | 2026-06 | nz | hl7 | Medication | |||
| fhir.org.nz.ig.base | R4 | StructureDefinition-NzMedication.json | Medication resource for use in NZ | draft | 2026-05 | us | hl7 | Medication | |||
| fhir.mamaToto | R4 | StructureDefinition-MedicationProfile.json | MedicationProfile | draft | 2026-07 | us | hl7 | Medication | |||
| de.gevko.emdaf | R4 | EMDAF_PR_Medication_Rezeptur.json | eMDAF Medikationsplan - Medication für Rezeptur | active | 2022-11 | Medication | 1 | ||||
| de.gevko.emdaf | R4 | EMDAF_PR_Medication_Wirkstoff.json | eMDAF Medikationsplan - Medication für Wirkstoff | active | 2022-11 | Medication | 1 | ||||
| de.gevko.emdaf | R4 | EMDAF_PR_Medication.json | eMDAF Medikationsplan - Medication | active | 2022-11 | Medication | 1 | ||||
| de.gematik.erp.t-prescription | R4 | StructureDefinition-erp-tprescription-medication.json | E-T-Rezept Medication | active | 2025-12 | Medication | 1 | ||||
| hl7.fhir.uv.ipa | R4 | StructureDefinition-ipa-medication.json | IPA-Medication | trial-use | pc | 2022-08 | uv | hl7 | Medication | 7 | |
| nexuzhealth.fhir.r4 | R4 | NxhAgentMedication.StructureDefinition.json | NxhAgentMedication | active | 2023-11 | Medication | |||||
| nexuzhealth.fhir.r4 | R4 | NxhChemoMedication.StructureDefinition.json | NxhChemoMedication | active | 2023-12 | Medication | |||||
| nexuzhealth.fhir.r4 | R4 | NxhCompoundMedication.StructureDefinition.json | NxhCompoundMedication | active | 2023-11 | Medication | |||||
| nexuzhealth.fhir.r4 | R4 | NxhInfusionMedication.StructureDefinition.json | NxhInfusionMedication | active | 2023-10 | Medication | |||||
| nexuzhealth.fhir.r4 | R4 | NxhMedication.StructureDefinition.json | NxhMedication | active | 2023-09 | Medication | |||||
| hl7.fhir.us.dme-orders | R4 | StructureDefinition-PAOX-Medication.json | PAO Medication | active | 2023-06 | us | hl7 | Medication | 1 | ||
| hl7.fhir.cz.hdr | R4 | StructureDefinition-cz-medication-hospitalstay-obl-hdr.json | Medication Obligations: (HDR CZ) - hospital stay | informative | 0 | 2026-07 | cz | hl7 | Medication | ||
| hl7.fhir.cz.hdr | R4 | StructureDefinition-cz-medication-medicationsummary-obl-hdr.json | Medication Obligations: (HDR CZ) - medication summary | informative | 0 | 2026-07 | cz | hl7 | Medication | ||
| bd.fhir.core | R4 | StructureDefinition-bd-medication.json | Medication Profile for Bangladesh-V2 | informative | 1 | 2025-10 | Medication | 1 | |||
| hl7.fhir.us.qicore | R4 | StructureDefinition-qicore-medication.json | QICore Medication | trial-use | 4 | cqi | 2018-08 | us | hl7 | Medication | 5 |
| fhir.onc.us-quality-core | R4 | StructureDefinition-us-quality-core-medication.json | US Quality Core Medication | active | 2026-06 | us | hl7 | Medication | 7 | ||
| hl7.fhir.us.quality-core | R4 | StructureDefinition-us-quality-core-medication.json | US Quality Core Medication | trial-use | 4 | cqi | 2026-06 | us | hl7 | Medication | 6 |
| hl7.fhir.ca.baseline | R4 | structuredefinition-profile-medication.json | Medication Profile | draft | 2024-12 | ca | hl7 | Medication | 5 | ||
| de.gematik.epa.research | R4 | StructureDefinition-epa-research-medication.json | Medication-Profil für ePA-Forschungsdaten | active | 2026-07 | Medication | |||||
| navify.fhir.r5.rdc | R5 | rdc-Medication.json | RDC Medication | draft | Medication | 1 | |||||
| ig-ee-medication-scheme | R5 | StructureDefinition-ee-tis-medication-renal-function.json | EETISMedicationRenalFunction | draft | 2024-02 | ee | Medication | ||||
| ig-ee-medication-scheme | R5 | StructureDefinition-ee-tis-medication-epc.json | EETISMedicationEPC | draft | 2024-02 | ee | Medication | 2 | |||
| hl7.fhir.uv.crmi | R4 | StructureDefinition-crmi-medicationdefinition.json | CRMI MedicationDefinition | trial-use | 1 | cds | 2026-07 | uv | hl7 | Medication | 2 |
| sfm.130323 | R4 | sfm-Medication.StructureDefinition.json | sfm-Medication | active | 2021-05 | Medication | 2 | ||||
| sfm.130323 | R4 | sfm-Nutrition.StructureDefinition.json | sfm-Nutrition | active | 2021-05 | Medication | 1 | ||||
| silfhirprofileig | R5 | StructureDefinition-medication.json | SGHI Medication | draft | 2026-05 | Medication | 3 | ||||
| ans.fhir.fr.eprescription | R4 | StructureDefinition-fr-medication-noncompound.json | FR Medication Non Compound | draft | 2026-07 | fr | Medication | 3 | |||
| fhir.iptpig | R4 | StructureDefinition-iptp-medication.json | IPTp SP Medication | draft | 2026-06 | us | hl7 | Medication | 1 | ||
| hl7.fhir.uv.crmi | R4 | StructureDefinition-crmi-publishablemedication.json | CRMI Publishable Medication | trial-use | 2 | cds | 2026-07 | uv | hl7 | Medication | |
| hl7.fhir.us.core | R4 | StructureDefinition-us-core-medication.json | US Core Medication Profile | trial-use | 5 | cgp | 2023-10 | us | hl7 | Medication | 62 |
| nictiz.fhir.nl.r4.nl-core | R4 | nl-core-PharmaceuticalProduct.json | nl core PharmaceuticalProduct | draft | nl | Medication | 3 | ||||
| nictiz.fhir.nl.r4.medicationprocess9 | R4 | mp-PharmaceuticalProduct.json | mp PharmaceuticalProduct | active | nl | Medication | 19 | ||||
| nictiz.fhir.nl.r4.immunization | R4 | imm-PharmaceuticalProduct.json | imm PharmaceuticalProduct | draft | 2024-07 | nl | Medication | 2 | |||
| nictiz.fhir.nl.r4.zib2020 | R4 | zib-PharmaceuticalProduct.json | zib PharmaceuticalProduct | draft | nl | hl7 | Medication | 1 | |||
| ehealth4u.package | R4 | CYEHRSDMedication.StructureDefinition.json | Cyprus EHR Medication profile | draft | 2022-03 | Medication | 1 | ||||
| qualitype.fhir.samples | R4 | StructureDefinition-MedicationCreate.json | MedicationCreate | active | Medication | 1 | |||||
| ch.fhir.ig.ch-ips | R4 | StructureDefinition-ch-ips-medication.json | CH IPS Medication | active | 2025-12 | ch | hl7 | Medication | 4 | ||
| nhsdigital.fhir.stu3 | R3 | CareConnect-DCH-Medication-1.json | CareConnect-DCH-Medication-1 | draft | phx | 2017-07 | Medication | 3 | |||
| nhsdigital.fhir.stu3 | R3 | CareConnect-GPC-Medication-1.json | CareConnect-GPC-Medication-1 | active | phx | 2019-11 | hl7 | Medication | 4 | ||
| nhsdigital.fhir.stu3 | R3 | CareConnect-ITK-Medication-1.json | CareConnect-ITK-Medication-1 | active | phx | 2018-10 | hl7 | Medication | 4 | ||
| careconnect.stu3.03.00.00 | R3 | CareConnect-Medication-1.json | CareConnect-Medication-1 | draft | phx | 2018-11 | hl7 | Medication | 30 | ||
| hl7.fhir.uv.pharm-quality | R5 | StructureDefinition-Medication-batch-information-drug-pq.json | Medication - Batch Information Drug PQ | active | brr | 2026-07 | uv | hl7 | Medication | 8 | |
| hl7.fhir.us.bser | R4 | StructureDefinition-BSeR-TobaccoUseCessationFeedbackMedication.json | BSeR Tobacco Use Cessation Feedback Medication | active | 2025-04 | us | hl7 | Medication | 1 | ||
| hl7.fhir.uv.xver-r2.r4b | R4B | StructureDefinition-profile-Medication.json | Cross-version Profile for DSTU2.Medication for use in FHIR R4B | trial-use | 0 | fhir | 2026-03 | uv | hl7 | Medication | 8 |
| hl7.fhir.uv.xver-r4.r4b | R4B | StructureDefinition-profile-Medication.json | Cross-version Profile for R4.Medication for use in FHIR R4B | trial-use | 0 | fhir | 2026-03 | uv | hl7 | Medication | 10 |
| hl7.fhir.uv.xver-r4b.r5 | R5 | StructureDefinition-profile-Medication.json | Cross-version Profile for R4B.Medication for use in FHIR R5 | trial-use | 0 | fhir | 2026-03 | uv | hl7 | Medication | 10 |
| hl7.fhir.uv.xver-r5.r4 | R4 | StructureDefinition-profile-Medication.json | Cross-version Profile for R5.Medication for use in FHIR R4 | trial-use | 0 | fhir | 2026-03 | uv | hl7 | Medication | 8 |
| hl7.fhir.uv.xver-r3.r4b | R4B | StructureDefinition-profile-Medication.json | Cross-version Profile for STU3.Medication for use in FHIR R4B | trial-use | 0 | fhir | 2026-03 | uv | hl7 | Medication | 8 |
| hl7.fhir.fi.base | R4 | StructureDefinition-fi-base-medication.json | FI Base Medication | active | 2025-10 | fi | hl7 | Medication | 6 | ||
| hl7.fhir.fi.smart | R4 | StructureDefinition-fi-smart-medication.json | FI SMART Medication | active | 2025-10 | fi | hl7 | Medication | |||
| hl7.fhir.fi.smart | R4 | StructureDefinition-fi-smart-medication-request.json | FI SMART Medication Request | active | 2025-10 | fi | hl7 | Medication | |||
| ltsi.fhir.oncofair | R5 | StructureDefinition-oncofair-medication.json | OncoFAIR Medication | active | 2025-11 | Medication | 5 | ||||
| ca.infoway.io.core | R4 | StructureDefinition-medication-ca-core.json | Medication (CA-Core) | active | 2 | 2025-03 | ca | national | Medication | 2 | |
| ch.fhir.ig.ch-ems | R4 | StructureDefinition-ch-ems-medication.json | CH EMS Medication | active | 2026-06 | ch | hl7 | Medication | 4 | ||
| myhealth.eu.fhir.eps | R4 | StructureDefinition-medication-eps-myhealtheu.json | Medication: MyHealth@EU EPS | draft | 1 | 2026-07 | eu | Medication | 2 | ||
| gov.cdc.nhsn.dqm | R4 | StructureDefinition-ach-daily-medication.json | ACH Daily Event Medication | trial-use | 1 | 2025-09 | us | Medication | |||
| gov.cdc.nhsn.dqm | R4 | StructureDefinition-ach-monthly-medication.json | ACH Monthly Event Medication | trial-use | 1 | 2025-09 | us | Medication | |||
| hl7.fhir.au.base | R4 | StructureDefinition-au-medication.json | AU Base Medication | trial-use | 2 | 2026-07 | au | hl7 | Medication | 1 | |
| ca.ab.fhir.psab | R4 | StructureDefinition-MedicationPSAB.json | Medication (PS-AB) | draft | ca | Medication | 1 | ||||
| ca.on.oh.patient-summary | R4 | MedicationPSON.json | Medication (PS-ON) | active | 2022-10 | ca | national | Medication | 2 | ||
| fhir.kenyaPSIG | R4 | StructureDefinition-ke-kps-medication.json | Medication Profile - KPS | draft | 2026-06 | us | hl7 | Medication | 1 | ||
| hl7.fhir.eu.mpd-r5 | R5 | StructureDefinition-Medication-eu-mpd.json | Medication: MPD | active | 2026-05 | eu | hl7 | Medication | 2 | ||
| hl7.fhir.eu.mpd | R4 | StructureDefinition-Medication-eu-mpd.json | Medication: MPD | active | 2026-05 | eu | hl7 | Medication | 2 | ||
| hl7.fhir.cz.img | R4 | StructureDefinition-cz-medication-obl-img.json | Medication: Obligations | draft | 2026-08 | cz | hl7 | Medication | |||
| hl7.fhir.eu.hdr | R4 | StructureDefinition-medication-obl-eu-hdr.json | Medication: obligations | informative | 0 | 2026-07 | eu | hl7 | Medication | 3 | |
| fhir.r4.ukcore.stu3.currentbuild | R4 | UKCore-Medication.json | UK Core Medication | active | 2023-12 | us | hl7 | Medication | 5 | ||
| fhir.deep6.ai | R4 | StructureDefinition-deep-6-ai-medication-1.0.2.json | Deep 6 AI Medication Profile | active | 2023-09 | us | hl7 | Medication | |||
| hl7.fhir.eu.base-r5 | R5 | StructureDefinition-medication-eu-core.json | Medication (EU core) | trial-use | 2 | 2026-04 | eu | hl7 | Medication | 5 | |
| hl7.fhir.eu.base | R4 | StructureDefinition-medication-eu-core.json | Medication (EU core) | trial-use | 2 | 2026-05 | eu | hl7 | Medication | 15 | |
| nictiz.fhir.nl.stu3.zib2017 | R3 | zib-Product.json | HCIM PharmaceuticalProduct | active | nl | hl7 | Medication | 10 | |||
| niceprofiling.v23q1 | R3 | NICE-Medication.json | NICE-Medication | active | 2021-11 | Medication | |||||
| hl7.fhir.uv.ips | R4 | StructureDefinition-Medication-uv-ips.json | Medication (IPS) | trial-use | 3 | pc | 2024-06 | uv | hl7 | Medication | 6 |
| ca.infoway.io.psca | R4 | StructureDefinition-medication-ca-ps.json | Medication (PS-CA) | draft | 2024-04 | ca | national | Medication | 4 | ||
| hl7.fhir.au.ps | R4 | StructureDefinition-au-ps-medication.json | AU PS Medication | trial-use | 2 | 2026-08 | au | hl7 | Medication | 3 | |
| hl7.fhir.au.core | R4 | StructureDefinition-au-core-medication.json | AU Core Medication | trial-use | 2 | 2026-05 | au | hl7 | Medication | 7 | |
| myhealth.eu.fhir.core | R4 | StructureDefinition-medication-myhealtheu-core.json | Medication (Core) | trial-use | 2 | 2026-05 | eu | Medication | 8 | ||
| myhealth.eu.fhir.epd | R4 | StructureDefinition-medication-myhealtheu-epd.json | Medication (EPD) | draft | 1 | 2026-07 | eu | Medication | 2 | ||
| csiro.fhir.au.smartforms | R4 | StructureDefinition-SHCMedication.json | Smart Health Checks Medication | draft | 2026-08 | au | Medication | 3 | |||
| csiro.fhir.au.gpccmp | R4 | StructureDefinition-GPCCMPMedication.json | GP CCMP Medication | draft | 2026-06 | Medication | 3 | ||||
| ndhm.in | R4 | StructureDefinition-Medication.json | Medication | draft | 2025-03 | in | national | Medication | 4 | ||
| hl7.fhir.us.davinci-crd | R4 | StructureDefinition-profile-medication.json | CRD Medication | trial-use | 4 | fm | 2026-05 | us | hl7 | Medication | 1 |
FHIR
FHIRsmith